Federal Judge Rules in Favor of Embryonic Stem-cell Research

By:  Dave Bohon
08/01/2011
       
Federal Judge Rules in Favor of Embryonic Stem-cell Research

A federal judge ruled July 27 that the U.S. government can continue funding embryonic stem-cell research. Royce Lamberth, chief judge of the District of Columbia District Court, threw out a 2009 lawsuit by researchers Dr. James Sherley and Theresa Deisher, of the Boston Biomedical Research Institute, that challenged President Obama’s expansion of funding for the research which pro-life leaders point out destroys human embryos. The funding had been severely limited under the Bush administration.

As reported by Baptist Press News, Lamberth issued the ruling “less than a year after suspending federal funding of embryonic stem cell research (ESCR).” Lamberth’s latest decision came “after the D.C. Circuit Court of Appeals removed his preliminary injunction on such grants.” In his opinion Lamberth said the appeals court decision “constrains this court,” compelling him to dismiss the challenge.

A federal judge ruled July 27 that the U.S. government can continue funding embryonic stem-cell research. Royce Lamberth, chief judge of the District of Columbia District Court, threw out a 2009 lawsuit by researchers Dr. James Sherley and Theresa Deisher, of the Boston Biomedical Research Institute, that challenged President Obama’s expansion of funding for the research which pro-life leaders point out destroys human embryos. The funding had been severely limited under the Bush administration.

As reported by Baptist Press News, Lamberth issued the ruling “less than a year after suspending federal funding of embryonic stem cell research (ESCR).” Lamberth’s latest decision came “after the D.C. Circuit Court of Appeals removed his preliminary injunction on such grants.” In his opinion Lamberth said the appeals court decision “constrains this court,” compelling him to dismiss the challenge.

Click here to read the entire article.

The JBS Weekly Member Update offers activism tips, new educational tools, upcoming events, and JBS perspective. Every Monday this e-newsletter will keep you informed on current action projects and offer insight into news events you won't hear from the mainstream media.
JBS Facebook JBS Twitter JBS YouTube JBS RSS Feed